Ledger.Open graph →
SEC Form D · filed February 25, 2021

Arch Therapeutics, Inc

Offering
$7.5M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James R. Sulat · Framingham, MADirectorPunit W. Dhillon · Framingham, MADirectorTerrence W. Norchi · Framingham, MAExec · DirectorRichard E. Davis · Framingham, MAExecEvan C. Weinstein · New York, NYExecPhilip C. Crane · Brooklyn, NYDirectorThomas Chen · Inglewood, CAExec · DirectorAndrew Goldberger · Tiburon, CADirectorPhillip B. Stern · Wilmington, DEExec · DirectorAhmed El Sarhan · George Town, Grand Cayman, Cayman IslandsExecMonika Mantilla · Coral Gables, FLDirectorStephen Carnes · Winter Park, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗